They’re found in home-testing kits for pregnancy, hospital tests for MRSA, and in six out of ten of the best-selling drugs today. But monoclonal antibodies have kept a surprisingly low profile since their debut in a Nature paper in 1975. This podcast follows them from that time through patent wars, promising drug trials and finally to blockbuster status today. Includes contributions from LMB’s Greg Winter.
Monoclonal antibodies; from their debut to blockbuster status
FORMA therapeutics and Cancer Research Technology to discover cancer drugs targeting deubiquitinating enzymes (DUBs)
LMB’s David Komander is part of collaborative consortium including FORMA Therapeutics and Cancer Research Technology, aiming to discover cancer drugs targeting deubiquitinating enzymes (DUBs). More…
What’s in a workspace? Brad Amos and his basement
Professor Brad Amos has spent much of his career designing and developing microscopes that are now used in laboratories around the world… He showed Sarah Harrop around the basement room he has worked in at the MRC Laboratory of Molecular Biology (LMB) for the last three decades… More…
MRC: 100 years of gratitude
As the MRC celebrates its centenary, THE looks at what has been achieved and how the MRC is funded. More…
Marc Torrent receives 2013 ICAAC Young Investigator Award
Dr Marc Torrent from the LMB’s Structural Studies Division has been honoured as a recipient of a 2013 ICAAC Young Investigator Award for his work to predict antimicrobial regions in proteins. This article is no longer available from the source website: ASM Society 26 June 2013
Gisela Perutz and the LMB canteen
The history behind the LMB’s canteen. More…